Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04949711 · ClinicalTrials.gov registry record · NA

Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility

A NA study of Alcohol Drinking and Driving Drunk, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
7,034
Enrollment target
1
Study location

NCT04949711 is a NA study of Alcohol Drinking and Driving Drunk that has completed, run by Columbia University. The registered enrollment target is 7,034 participants, above the 548-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (1184% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04949711, a NA study of Alcohol Drinking and Driving Drunk, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
7,034 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to understand people's alcohol use in public places and their risks for harm. The overall goal of this study is to test the effects of subsidized ridesharing as an intervention to reduce self-reported alcohol-impaired driving, along with alcohol consumption and changes to mobility.

Interventions

  • BEHAVIORAL ridesharing voucher
  • BEHAVIORAL online shopping voucher

Study Locations (1)

New York

  • Columbia University Irving Medical Center - New York

Trial Details

FieldValue
Enrollment Target 7,034 participants
Start Date 2022-05-01
Est. Completion 2025-04-04
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT04949711

The ClinicalTrials.gov registry entry for NCT04949711 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,034 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 548-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (1184% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 2 interventions - of which ridesharing voucher is the first listed.

NCT04949711 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04949711 about?

NCT04949711 is a clinical study titled "Impacts of Subsidized Ridesharing on Drunk Driving, Alcohol Consumption, and Mobility". The purpose of this research study is to understand people's alcohol use in public places and their risks for harm. The overall goal of this study is to test the effects of subsidized ridesharing as an intervention to reduce self-reported alcohol-impaired driving, along with alcohol consumption and ...

What is the current status of trial NCT04949711?

This trial is currently completed. It is a NA study. The enrollment target is 7,034 participants. The study started on 2022-05-01. Estimated completion is 2025-04-04.

What conditions does trial NCT04949711 study?

This clinical trial studies the following conditions: Alcohol Drinking, Driving Drunk.

What interventions are being tested in trial NCT04949711?

The interventions under investigation include: ridesharing voucher (BEHAVIORAL), online shopping voucher (BEHAVIORAL).

Who is sponsoring clinical trial NCT04949711?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04949711 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.